This ASX biotech stock could be the next M&A target
Joanne TranMarkets reporter
Andrew Hamilton is a portfolio manager at Antares Equities. The Melbourne-based firm oversees about $5.7 billion.
Which stock in your funds could be an M&A target and why?
Loading...
Joanne Tran is a markets reporter for The Australian Financial Review in the Sydney newsroom. Connect with Joanne on Twitter. Email Joanne at jo.tran@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles